Seeking Alpha

Arrowhead Research Corporation (ARWR)

  • vnmonk | Send Message 29 Jul

    Harnessing the Power of RNAi Gene Silencing in Quest of Cure for Chronic Hepatitis B $ARWR
      • Kanak Kanti De | Send Message 17 Jul

        Market Continues To Underestimate The Potential Of Arrowhead's ARC-520 $ARWR
          • WItrader18 | Send Message 7 Jul

            Bought back $ARWR at $6.70 after selling at $7.20
            Reply (1)
            • matratra | Send Message 7 Jul
              : a great buy at this price.
              • SA Editor Mike Taylor | Send Message 6 Jul

                Premarket Biotech Digest: $ARWR's new trial, approval for $VRTX, insider sales
                  • Kanak Kanti De | Send Message 6 Jul

                    Premarket Biotech Digest: Arrowhead Initiates Dosing, Vertex Orkambi Approval, Insider Sales $ARWR
                      • jgtragesser | Send Message 25 Jun

                        $ARWR Receives Reg Clearance to Begin Additional Ph 2b Studies of Hep B Candidate ARC-520...
                          • WItrader18 | Send Message 19 Jun

                            Sold $ARWR from buy on 4/21 $6.75 --> $7.20 + $0.45 covered call option expired on 5/15 for 13.3% gain
                            Reply (21)
                          • View all 21 replies
                            • tradebr2010 | Send Message 19 Jun
                              : I think you could count on profit x margin if you sell a naked call/put.
                            • WItrader18 | Send Message 7 Jul
                              : Back in $6.70
                              • creepus | Send Message 17 Jun

                                Swing Trading Ideas - Charts $CVEO $VIP $DNR $PVA $GALT $OREX $HIMX $ARWR $SGYP $AXPW $ARTX
                                  • ScottyGreen | Send Message 3 Jun

                                    $ARWR NICE! on 6/3/15 at Jefferies conference, CEO Chris Anzalone just stated that they are "about 2 years ahead of the competition" in HBV
                                    Reply (1)
                                    • WItrader18 | Send Message 3 Jun
                                      : Nice! is right! Thanks for the update
                                      • WItrader18 | Send Message 15 May

                                        $ARWR $7 cc options expiring today worthless, unless a massive pop comes :)
                                          Visit Seeking Alpha's
                                          ARWR vs. ETF Alternatives
                                          Company Description
                                          Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States